{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:57:18Z","timestamp":1790675838912,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.clgc.2013.11.002","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T18:40:14Z","timestamp":1384281614000},"page":"155-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["[11C]Choline PET\/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy"],"prefix":"10.1016","volume":"12","author":[{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rodari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8895-9165","authenticated-orcid":false,"given":"Maria","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6509-3605","authenticated-orcid":false,"given":"Paola","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egesta","family":"Lopci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Zerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vischioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliu Victor","family":"Matei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2013.11.002_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2007.04.013","article-title":"Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer","volume":"84","author":"Jereczek-Fossa","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2013.11.002_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/radiol.2431030580","article-title":"Imaging prostate cancer: a multidisciplinary perspective","volume":"243","author":"Hricak","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.clgc.2013.11.002_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CCO.0b013e3280ad439b","article-title":"Imaging of prostate cancer","volume":"19","author":"Oher","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clgc.2013.11.002_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(10)70103-0","article-title":"Radionuclide and hybrid imaging of recurrent prostate cancer","volume":"12","author":"Beer","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2013.11.002_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000083551","article-title":"11C choline positron emission tomography in prostate cancer: primary staging and recurrent site staging","volume":"74","author":"Yoshida","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2013.11.002_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00259-007-0530-2","article-title":"[(11)C]choline PET\/CT imaging in occult local relapse of prostate cancer after radical prostatectomy","volume":"35","author":"Reske","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2013.11.002_bib7","first-page":"1337","article-title":"Value of [11C]choline positron emission tomography for restaging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography","volume":"169","author":"Picchio","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2013.11.002_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","article-title":"Evaluation of [(18)F]- choline PET\/CT for staging and restaging of prostate cancer","volume":"35","author":"Husarik","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2013.11.002_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2013.04.019","article-title":"The role of 11C-Choline and 18F-fluorocholine positron emission tomography (PET) and PET\/CT in prostate cancer: a systematic review and meta-analysis","volume":"64","author":"Umbehr","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2013.11.002_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7150\/thno.4008","article-title":"Choline PET and PET\/CT in primary diagnosis and staging of prostate cancer","volume":"2","author":"Schwarzenb\u00f6ck","year":"2012","journal-title":"Theranostics"},{"key":"10.1016\/j.clgc.2013.11.002_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0302-2838(03)00207-0","article-title":"[11C]choline positron emission tomography for the evaluation after treatment of localized prostate cancer","volume":"44","author":"De Jong","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2013.11.002_bib12","unstructured":"Rete Oncologica Lombarda. Available at: http:\/\/www.progettorol.it\/doc\/LLGG\/ROL_Prostata_Terapia_novembre_2011.pdf. Accessed: September\u00a02012."},{"key":"10.1016\/j.clgc.2013.11.002_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"EAU guidelines on prostate cancer. Part\u00a01: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2013.11.002_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2011.01.025","article-title":"EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"59","author":"Mottet","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2013.11.002_bib15","unstructured":"Prostate cancer. In: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, version 1.2012. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed: September\u00a02012."},{"key":"10.1016\/j.clgc.2013.11.002_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2009.04.001","article-title":"Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer","volume":"93","author":"Jereczek-Fossa","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2013.11.002_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ijrobp.2010.11.031","article-title":"Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastastic prostate cancer","volume":"82","author":"Jereczek-Fossa","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2013.11.002_bib18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ctrv.2012.05.005","article-title":"Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm","volume":"38","author":"Cr\u00e9hange","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clgc.2013.11.002_bib19","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2013.11.002_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1748-717X-7-204","article-title":"Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal\/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients","volume":"7","author":"Alongi","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clgc.2013.11.002_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clgc.2012.08.003","article-title":"Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy","volume":"11","author":"Berkovic","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2013.11.002_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/030089161209800201","article-title":"PET scan contribution in chest tumor management: a systematic review for thoracic surgeons","volume":"8","author":"Duranti","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.clgc.2013.11.002_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.gtc.2009.01.007","article-title":"The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction","volume":"38","author":"Yoon","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.clgc.2013.11.002_bib24","first-page":"487","article-title":"Role of FDG-PET\/CT in staging and follow-up of head and neck squamous cell carcinoma. Q","volume":"55","author":"Mak","year":"2011","journal-title":"J\u00a0Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2013.11.002_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/pcan.2011.35","article-title":"18F-fluorocholine for prostate cancer imaging: a systematic review of the literature","volume":"15","author":"Bauman","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2013.11.002_bib26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1586\/era.11.51","article-title":"PET and PET\/CT in radiation treatment planning for prostate cancer","volume":"11","author":"Pinkawa","year":"2011","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767313002711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767313002711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:22:35Z","timestamp":1761564155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767313002711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1558767313002711"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2013.11.002","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[11C]Choline PET\/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}